News2 mins ago
Health Canada accepts New Drug Submission for lecanemab as treatment for early Alzheimer’s disease
STOCKHOLM, May 16, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has accepted a New Drug Submission...
